Syndicate This week's upcoming IPO's and secondary offerings

Week of October 23 to October 27, 2024

This Day's Priced Deals: October 26th, 2017

Symbol

Issuer

Type

Price

Managers

BPMP

BP Midstream
BP Midstream
IPO
Priced: $18.00
42.5M
Citi,...

Pricing after close
Deal analysis and details

Managers: Citi, Goldman Sachs & Morgan Stanley, Barclays, Credit Suisse, JPMorgan, UBS, BofA, Deutsche Bank, MIZU, BNP Paribas, LYON, Societe Generale

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
EYE

National Vision
National Vision
IPO
Priced: $22.00
15.8M
BofA,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: BofA, Goldman Sachs, Citi & KKRG, Morgan Stanley, Jefferies, UBS, Wells Fargo, Guggenheim, Mizuho, Macquarie

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
ATOS

Atossa Genetics
Atossa Genetics
Secondary
Priced: $.44
11.5M
Maxim

Pricing after close

Managers: Maxim

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
CWH

Camping World
Camping World
Secondary
Priced: $40.50
6.7M
Goldman Sachs & JPMorgan,...

Pricing after close
Deal analysis and details

Managers: Goldman Sachs & JPMorgan, BofA, Credit Suisse, Baird, BMO Capital, KeyBanc, Stephens, Wells Fargo

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
HCM

Hutchison China MediTech
Hutchison China MediTech
Secondary
Priced: $26.50
9.887M
BofA & Deutsche Bank,...

Pricing after close
Deal analysis and details

Managers: BofA & Deutsche Bank, Stifel, Canaccord, Panmure Gordon, CITIC CLSA

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
IDRA

Idera Pharmaceuticals
Idera Pharmaceuticals
Secondary
Priced: $1.50
33.333M
JPMorgan & Goldman Sachs,...

Pricing after close
Deal analysis and details

Managers: JPMorgan & Goldman Sachs, Barclays

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
HLI

Houlihan Lokey
Houlihan Lokey
Spot Secondary
Priced: $42.00
3.5M
Morgan Stanley

Pricing after close
Deal analysis and details

Managers: Morgan Stanley

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
VBIV

VBI Vaccines
VBI Vaccines
Spot Secondary
Priced: $3.05
4.2M
BMO Capital & Canaccord,...

Pricing after close
Deal analysis and details

Managers: BMO Capital & Canaccord, Ladenburg

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

This Week's Deals to be Priced

10/24 - Tuesday

Symbol

Issuer

Type

Price

Managers

SALT

Scorpio Bulkers
Scorpio Bulkers
Spot Secondary
Cancelled $7.70-8.10
10M
Morgan Stanley,...

Pricing after close

Managers: Morgan Stanley, Clarksons Platou, GHSC

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

This Week's Priced Deals

10/23 - Monday

Symbol

Issuer

Type

Price

Managers

CRBP

Corbus Pharmaceuticals
Corbus Pharmaceuticals
Spot Secondary
Priced: $7.00
4.65M
Cantor Fitzgerald

Pricing after close
Deal analysis and details

Managers: Cantor Fitzgerald

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
FRC

First Republic
First Republic
Spot Secondary
Priced: $97.30
2.5M
BofA,...

Pricing after close
Deal analysis and details

Managers: BofA, Goldman Sachs, JPMorgan, Morgan Stanley & UBS

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

10/24 - Tuesday

Symbol

Issuer

Type

Price

Managers

ABLX

Ablynx
Ablynx
IPO
Priced: $17.50
11.43M
BofA,...

Pricing after close
Deal analysis and details

Managers: BofA, JPMorgan & Jefferies, Baird, Byran, Ladenburg

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
IMDZ

Immune Design
Immune Design
Secondary
Priced: $4.10
19.5M
Leerink,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: Leerink, TD Cowen & RBC Capital

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
QURE

uniQure
uniQure
Secondary
Priced: $18.25
5M
Leerink & Evercore ISI,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: Leerink & Evercore ISI, Chardan

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
SACH

Sachem Capital
Sachem Capital
Secondary
Priced: $4.00
3.75M
FBRC & Joseph Gunnar

Pricing after close
Deal analysis and details

Managers: FBRC & Joseph Gunnar

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
PFLT

PennantPark Floating Rate
PennantPark Floating Rate
Spot Secondary
Priced: $14.15
6M
Morgan Stanley,...

Pricing after close
Deal analysis and details

Managers: Morgan Stanley, Goldman Sachs, JMP Securities, Keefe Bruyette, Stifel & Truist

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
SNSS

Sunesis
Sunesis
Spot Secondary
Priced: $2.00
7.5M
TD Cowen & Wells Fargo,...

Pricing after close
Deal analysis and details

Managers: TD Cowen & Wells Fargo, Oppenheimer

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
SVRA

Savara
Savara
Spot Secondary
Priced: $7.85
5.25M
TD Cowen & Wells Fargo,...

Pricing after close
Deal analysis and details

Managers: TD Cowen & Wells Fargo, Oppenheimer

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

10/25 - Wednesday

Symbol

Issuer

Type

Price

Managers

BK

Bank of New York
Bank of New York
Block Trade
Priced: $52.45
4.5M
BofA

Pre-open pricing
Deal analysis and details

Managers: BofA

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
BPMP

BP Midstream
BP Midstream
IPO
Priced: $18.00
42.5M
Citi,...

Pricing after close
Deal analysis and details

Managers: Citi, Goldman Sachs & Morgan Stanley, Barclays, Credit Suisse, JPMorgan, UBS, BofA, Deutsche Bank, MIZU, BNP Paribas, LYON, Societe Generale

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
EYE

National Vision
National Vision
IPO
Priced: $22.00
15.8M
BofA,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: BofA, Goldman Sachs, Citi & KKRG, Morgan Stanley, Jefferies, UBS, Wells Fargo, Guggenheim, Mizuho, Macquarie

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
ATOS

Atossa Genetics
Atossa Genetics
Secondary
Priced: $.44
11.5M
Maxim

Pricing after close

Managers: Maxim

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
CWH

Camping World
Camping World
Secondary
Priced: $40.50
6.7M
Goldman Sachs & JPMorgan,...

Pricing after close
Deal analysis and details

Managers: Goldman Sachs & JPMorgan, BofA, Credit Suisse, Baird, BMO Capital, KeyBanc, Stephens, Wells Fargo

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
HCM

Hutchison China MediTech
Hutchison China MediTech
Secondary
Priced: $26.50
9.887M
BofA & Deutsche Bank,...

Pricing after close
Deal analysis and details

Managers: BofA & Deutsche Bank, Stifel, Canaccord, Panmure Gordon, CITIC CLSA

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
IDRA

Idera Pharmaceuticals
Idera Pharmaceuticals
Secondary
Priced: $1.50
33.333M
JPMorgan & Goldman Sachs,...

Pricing after close
Deal analysis and details

Managers: JPMorgan & Goldman Sachs, Barclays

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
HLI

Houlihan Lokey
Houlihan Lokey
Spot Secondary
Priced: $42.00
3.5M
Morgan Stanley

Pricing after close
Deal analysis and details

Managers: Morgan Stanley

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
VBIV

VBI Vaccines
VBI Vaccines
Spot Secondary
Priced: $3.05
4.2M
BMO Capital & Canaccord,...

Pricing after close
Deal analysis and details

Managers: BMO Capital & Canaccord, Ladenburg

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

10/26 - Thursday

Symbol

Issuer

Type

Price

Managers

FSCT

ForeScout
ForeScout
IPO
Priced: $22.00
5.3M
Morgan Stanley,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: Morgan Stanley, JPMorgan & Citi, BofA, UBS, KeyBanc

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
MBIN

Merchants Bancorp
Merchants Bancorp
IPO
Priced: $16.00
6.2M
Sandler O'Neill & Stephens,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: Sandler O'Neill & Stephens, Raymond James, Truist

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
NEXA

Nexa Resources
Nexa Resources
IPO
Priced: $16.00
31M
JPMorgan,...

Pricing after close
Deal analysis and details

Managers: JPMorgan, BMO Capital, Morgan Stanley & Credit Suisse, BofA, Citi, Scotiabank, Bradesco, Credicorp

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
FBMS

First Bancshares
First Bancshares
Secondary
Priced: $29.00
1.75M
Keefe Bruyette,...

Pricing after close
Deal analysis and details

Managers: Keefe Bruyette, Fig Partners

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
IRCP

IRSA CP
IRSA CP
Secondary
Priced: $55.00
1.75M
JPMorgan

Pricing after close

Managers: JPMorgan

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
EIGR

Eiger BioPharmaceuticals
Eiger BioPharmaceuticals
Spot Secondary
Priced: $10.00
1.85M
BTIG

Pricing after close
Deal analysis and details

Managers: BTIG

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

No Date Assigned

Symbol

Issuer

Type

Price

Managers

LXL

LiveXLive Media
LiveXLive Media
IPO
$4.00

BMO Capital,...

Pricing after close
Deal analysis and details

Managers: BMO Capital, JMP Securities, Craig-Hallum

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

Get Full Fly Access

Breaking market intelligence sent straight to you: Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.

Up-to-date information on important industry events: Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.

News focused on the companies in your portfolio: Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.

14 Day Free Trial

Learn more »